Licensing


Captisol® is a well-profiled enabling technology available to research and development professionals through flexible licensing arrangements. We work worldwide with companies interested in licensing Captisol® and other SBE-CD technologies to commercialize their products. We also work with our partners to manage life cycles of existing products.

  • Pharmaceutical Product Development services
  • Commercial License and Supply Agreement (LSA)
  • Limited Clinical Use Agreements (LCUAs)
Back to Top